Odyssey Therapeutics Inc.

ODTX | NASDAQ

Price Alert Chart Builder DCF Calculator

$19.54

-$0.29 (-1.46%)

At close: Oct 30, 2026, 4:00 PM ET

$19.54

$0.00 (0.00%)

After-hours: Oct 30, 2026, 4:18 PM ET

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Market Data

Market Cap $939.06M

Enterprise Value $653.31M

Beta 1.43

Average Volume 267.41K

Shares Outstanding (Diluted) 30.28M

Shares Change YoY N/A

Institutional Ownership N/A

Exchange NASDAQ

ISIN US67613T1043

Price Performance

Price Change 1M -12.1%

Price Change 3M 3.2%

Price Change 6M N/A

Price Change YTD N/A

Price Change 1Y N/A

Price Change 3Y N/A

Price Change 5Y N/A

1M CAGR (ann.) -19.9%

1Y CAGR (ann.) N/A

5Y CAGR (ann.) N/A

All-Time CAGR 43.7%

Valuation

PE Ratio -7.66

Forward PE N/A

PEG Ratio -0.08

Forward PEG 0.09

PS Ratio N/A

Forward PS 315.50

PB Ratio 2.23

P/FCF Ratio -12.38

P/Adj. FCF Ratio -11.16

P/OCF Ratio -7.82

EV/Sales N/A

EV/EBIT -7.18

EV/EBITDA -7.36

EV/FCF -8.61

Earnings Yield -13.1%

FCF Yield -8.1%

Adj. FCF Yield -9.0%

Financial Health

Net Cash $310.58M

Total Debt $24.83M

Cash & Short-Term Investments $310.58M

Total Assets $483.85M

Current Ratio 11.36

Quick Ratio 11.36

Debt / Equity Ratio 0.06

Debt / EBITDA -0.28

Debt / FCF -0.33

OCF / Debt -3.04

Interest Coverage -3,175.00

Altman Z-Score 7.20

Piotroski F-Score 1

Margins & Profitability

Gross Profit Margin 0.0%

Operating Profit Margin 0.0%

EBITDA Margin 0.0%

Net Profit Margin 0.0%

FCF Margin N/A

Adj. FCF Margin N/A

SBC / Revenue 0.0%

SBC Impact (per share) -10.9%

Returns

Return on Assets -18.8%

Return on Equity 177.7%

Return on Invested Capital -20.7%

Return on Capital Employed -20.9%

Return on Tangible Assets -19.4%

Analyst Forecasts

Analyst Rating Buy

Analyst Count 2

EPS Growth Next 3Y -31.8%

Revenue Growth Next 3Y N/A

Earnings Date Nov 4, 2026

EPS Estimate (next Q) -$1.13

EPS Growth Est (next Q) N/A

Revenue Est (next Q) N/A

Revenue Growth Est (next Q) N/A

Fair Value Estimates

Graham Number N/A

Graham Upside N/A

Lynch Fair Value N/A

Lynch Upside N/A

Price Target $36.60

Price Target Upside 87.3%

Cash Flow

Operating Cash Flow $-75.54M

Free Cash Flow $-75.88M

Adj. Free Cash Flow $-84.14M

FCF Per Share -$2.51

OCF Per Share -$2.50

OCF/S Ratio 0.0%

Income Statement

Revenue $0

Gross Profit $0

Operating Income $-95.25M

EBITDA $-88.75M

Net Income $-91.05M

EPS (Diluted) -$2.55

Revenue / Employee N/A

Profit / Employee $-910.5K

Employees 100